PHARMACOLOGICAL INTERACTION BETWEEN NITROGLYCERIN AND ASPIRIN AFTER ACUTE AND CHRONIC ASPIRIN TREATMENT OF HEALTHY-SUBJECTS

被引：12

作者：

REY, E

ELASSAF, HD

RICHARD, MO

WEBER, S

BOURDON, A

PICARD, G

OLIVE, G

机构：

[1] HOP ST VINCENT PAUL,DEPT PHARMACOL CLIN,F-75674 PARIS 14,FRANCE

[2] HOP COCHIN,SERV CARDIOL,F-75674 PARIS 14,FRANCE

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 25卷 / 06期

关键词：

D O I：

10.1007/BF00542519

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：779 / 782

页数：4

共 21 条

[1] BLOOD-LEVELS AFTER SUB-LINGUAL NITROGLYCERIN [J].

ARMSTRONG, PW ;

ARMSTRONG, JA ;

MARKS, GS .

CIRCULATION, 1979, 59 (03) :585-588

[2]

ARMSTRONG PW, 1980, NOUV PRESSE MED, V9, P2429

[3]

BLUMENTHAL HP, 1977, BRIT J CLIN PHARMACO, V4, P241

[4]

BORY M, 1979, NOUV PRESSE MED, V8, P279

[5] INHIBITION OF PLATELET PROSTAGLANDIN SYNTHETASE BY ORAL ASPIRIN [J].

BURCH, JW ;

STANFORD, N ;

MAJERUS, PW .

JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (02) :314-319

[6] EFFECT OF INHIBITORS OF PROSTAGLANDIN SYNTHESIS ON HEPATIC DRUG CLEARANCE [J].

FEELY, J ;

WOOD, AJJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (01) :109-111

[7]

GIRRE C, 1980, NOUV PRESSE MED, V9, P2433

[8]

GOLD HK, 1972, CIRCULATION, V46, P839, DOI 10.1161/01.CIR.46.5.839

[9]

GOODMAN LS, 1980, PHARM BASIS THERAPEU

[10] DIFFERENCE IN NITROGLYCERIN DOSE-RESPONSE IN THE VENOUS AND ARTERIAL BEDS [J].

IMHOF, PR ;

OTT, B ;

FRANKHAUSER, P ;

CHU, LC ;

HODLER, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (06) :455-460

← 1 2 3 →